GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates announced today that it has entered into a collaborative oncology drug discovery and translation research agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
